Mitochondrial antioxidant MitoQ reduces Alzheimer's pathology in symptomatic mice
Oral treatment improved behavioral deficits, suppressed amyloid plaques, lowered neuroinflammation, and restored mitochondrial quality control in mice with established disease.
Aging and disease · Kumar M et al. · Paper published 22 Sep 2026
In a study of four-month-old 5XFAD mice, researchers evaluated the effects of oral treatment with the mitochondria-targeted antioxidant MitoQ10. The mice received the compound for four months and underwent testing at eight months of age. MitoQ improved novelty-related exploration and reduced hyper-locomotor activity. It broadly suppressed amyloid pathology across the cortex, hippocampus, thalamus, and amygdala, reducing pan-Aβ, oligomeric Aβ species, fibrillar plaques, and mature deposits. MitoQ also reduced pathological pTau622, attenuated astrocyte and microglial reactivation, and preserved neuronal integrity. Furthermore, the intervention increased PDH-positive mitochondrial particle area, lowered oxidative DNA damage, and normalized mitophagy-associated quality-control markers in animals with established pathology.
Why it matters
Mitochondrial dysfunction and oxidative stress are core hallmarks of aging that exacerbate neurodegeneration. Restoring mitochondrial redox balance offers a potential path to target amyloid burden, tau pathology, and neuroinflammation concurrently.
Caveats
The findings are limited to an animal model of Alzheimer's disease. Direct clinical studies are still required to assess the safety and efficacy of MitoQ in human patients with the condition.
Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.
The paper
Repurposing MitoQ10 as a Therapeutic for Established Alzheimer's Disease Pathology
Kumar M, Ray S, Sil S
Aging and disease · 22 Sep 2026 · Peer-reviewed
- Relevance
- Relevant
- News value
- Notable
- Evidence
- Animals
- Status
- Peer-reviewed
More on Mitochondria
See allCardiolipin loss drives muscle fiber shifts during aging via a nuclear receptor
Restoring cardiolipin synthesis in knockout mice reversed muscle atrophy and prevented premature death.
Nature aging · Finger F et al.
Early-life mitochondrial DNA mutations drive age-related pathology in mice
Manipulating mitochondrial fusion can alter tissue-specific selection against deleterious variants that arise early in development.
bioRxiv · Shemtov SJ et al.
Inhibiting miR-128-3p restores muscle mass and function in aged mice
The microRNA inhibitor also improved cardiac outcomes after infarction and reduced pathology in mouse and pig models of muscular dystrophy.
bioRxiv : the preprint server for biology · Boldridge MA et al.
Prodh2 inhibition alleviates muscle atrophy and restores strength in COPD mice
TNF-alpha triggers a mitochondrial immune pathway via Prodh2 that damages myoblasts, while silencing the enzyme restores muscle strength in mice.
Aging cell · Chen G et al.
Depp1 drives muscle loss under fasting and low oxygen in mice
The study reveals that the protein localizes to mitochondria to regulate autophagy and mitochondrial degradation during nutrient and oxygen limitation.
bioRxiv · Qayyum S et al.